A. Moran

发表

Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

D. Evans, S. Huson, A. Shenton, 2007, Journal of Medical Genetics.

Life expectancy in hereditary cancer predisposing diseases: an observational study

D. Evans, S. Huson, F. Lalloo, 2012, Journal of Medical Genetics.

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years

A. Howell, C. Todd, M. Campbell, 2007, British Journal of Cancer.

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Andrew Shenton, Sheila Seal, Anthony Howell, 2006, European journal of cancer.

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

A. Howell, D. Evans, F. Lalloo, 2010, British Journal of Cancer.

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989

D. Evans, S. Huson, A. Moran, 2011, European Journal of Human Genetics.

A genetic register for von Hippel-Lindau disease.

R. Whitehouse, D. Evans, M. Teare, 1996, Journal of medical genetics.

Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-year Period: Higher Incidence than Previously Thought

D. Evans, R. Ramsden, D. G. Evans, 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

High cancer mortality rates in the elderly in the UK.

A. Moran, H. Møller, G. Flatt, 2011, Cancer epidemiology.

Survival from cancer in teenagers and young adults in England, 1979–2003

M. Geraci, J. Birch, T. Eden, 2008, British Journal of Cancer.

Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England

M. Stevens, C. Stiller, M. McCabe, 2017, BMJ Open.

Bladder cancer: worse survival in women from deprived areas

N. Clarke, S. Collins, A. Sowerbutts, 2004, British Journal of Cancer.

Place of treatment for teenagers and young adults diagnosed with cancer 2003 to 2005

M. McCabe, A. Moran, C. O'Hara, 2012 .

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989

J. Ragoussis, R. Copley, D. Evans, 2013, European Journal of Human Genetics.

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

D. Evans, M. Baser, E. Howard, 2002, Journal of medical genetics.

Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

D. Evans, M. Baser, B. Timms, 2001 .

Ovarian cancer among 8005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2

I. Buchan, J. Warwick, A. Howell, 2013, Journal of Medical Genetics.

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

Sofia Khan, D. Evans, F. Lalloo, 2012, Familial Cancer.

Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.

D. Evans, S. Huson, J. Wylie, 2011, European journal of cancer.

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

P. Pharoah, D. Evans, J. Varley, 2003, The Lancet.

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

Sofia Khan, F. Lalloo, E. Maher, 2011, Familial Cancer.

Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.

J. Birch, T. Eden, A. Moran, 2009, Neuro-oncology.

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

D. Evans, A. Shenton, F. Lalloo, 2006, Journal of Medical Genetics.

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

A Howell, A. Howell, D. Evans, 2003, Journal of medical genetics.

Cancer mortality in 13 to 29-year-olds in England and Wales, 1981–2005

M. Geraci, J. Birch, T. Eden, 2007, British Journal of Cancer.

Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003.

M. Geraci, J. Birch, T. Eden, 2010, European journal of cancer.

Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979‒2003

M. Geraci, J. Birch, T. Eden, 2008, Cancer.

Trends in survival for teenagers and young adults with cancer in the UK 1992–2006

M. Stevens, C. Stiller, M. McCabe, 2015, European journal of cancer.

Older women with operable breast cancer are less likely to have surgery

A. Howell, C. Todd, M. Campbell, 2007, The British journal of surgery.

Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groups.

C. Stiller, D. Bowen, R. Feltbower, 2015, European journal of cancer.

Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England

J. Birch, T. Eden, A. Moran, 2007, British Journal of Cancer.

Geographical and temporal distribution of cancer survival in teenagers and young adults in England

M. Geraci, J. Birch, T. Eden, 2009, British Journal of Cancer.

Cancer at ages 15–29 years: The contrasting incidence in India and England

M. Geraci, J. Birch, T. Eden, 2012, Pediatric blood & cancer.

Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater.

S. Collins, A. Moran, R. Davies, 1997, British Journal of Cancer.